Research compendium
AOD-9604
AOD-9604 is based on a C-terminal growth-hormone region with a modification relative to the original segment. It has been studied in animal metabolic models and analytical research. It is not automatically synonymous with native hGH fragment 176–191.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Sequence origin and measured compartment
Do not turn a name’s origin into a localization or function claim. Preserve the specific evidence connecting sequence, detection and response.
- Does the work distinguish a proposed sequence, detected peptide and synthesized material?
- Which compartment or model supplies the signal being interpreted?
- Is the functional readout compared with appropriate system controls?
Mechanism described in the literature
Mouse research examined beta-adrenergic pathway involvement. Animals without the beta-3 receptor showed differences between acute and prolonged findings. The study itself did not support a simple direct action at that receptor.
Classification
Peptide analog of a growth-hormone segment
Other names
- AOD9604
The fragment name is insufficient
The analytical paper defines AOD-9604 as an hGH segment with an N-terminal modification. It must therefore remain distinct from full growth hormone and the native fragment. Abbreviated names omitting that difference cannot assign evidence precisely.
A relevant mechanistic discrepancy
In beta-3-receptor-deficient mice, some prolonged responses observed in controls were absent while acute energy-expenditure and fat-oxidation changes persisted. This prevents summarizing the study as direct beta-3 agonism or combining every endpoint under one functional label.
Detecting a metabolite does not establish its function
Analytical work identified products after serum and urine incubation in vitro, with persistence differing from the starting compound. The purpose was detection. A more persistent molecular species can be a useful analytical marker without demonstrated equivalent biological activity.
Questions and answers
Is AOD-9604 equivalent to native fragment 176–191?
No. The analog’s definition includes a modification and must retain its independent identity.
Does metabolite persistence indicate response duration?
No. Chemical detection and functional duration require different measurements.
Sources
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. — Endocrinology (2001); PMID 11713213; DOI 10.1210/endo.142.12.8522
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. — Endocrinology (2001); PMID 11713213; DOI 10.1210/endo.142.12.8522
- Detection and in vitro metabolism of AOD9604. — Drug Test Anal (2015); PMID 25208511; DOI 10.1002/dta.1715
- Detection and in vitro metabolism of AOD9604. — Drug Test Anal (2015); PMID 25208511; DOI 10.1002/dta.1715